Literature DB >> 22797639

Is it time to replace the tuberculin skin test with a blood test?

Philip A LoBue1, Kenneth G Castro.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22797639      PMCID： PMC4629850          DOI： 10.1001/jama.2012.7511

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers.

Authors:  Sumanth Gandra; William S Scott; Vijaya Somaraju; Huaping Wang; Suzanne Wilton; Michelle Feigenbaum
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10-27       Impact factor: 3.254

2.  Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.

Authors:  F Marra; C A Marra; M Sadatsafavi; O Morán-Mendoza; V Cook; R K Elwood; M Morshed; R C Brunham; J M Fitzgerald
Journal:  Int J Tuberc Lung Dis       Date:  2008-12       Impact factor: 2.373

3.  Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Authors:  Gerald H Mazurek; John Jereb; Andrew Vernon; Phillip LoBue; Stefan Goldberg; Kenneth Castro
Journal:  MMWR Recomm Rep       Date:  2010-06-25

4.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

5.  Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.

Authors:  Marie A de Perio; Joel Tsevat; Gary A Roselle; Stephen M Kralovic; Mark H Eckman
Journal:  Arch Intern Med       Date:  2009-01-26

Review 6.  Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

Authors:  Madhukar Pai; Alice Zwerling; Dick Menzies
Journal:  Ann Intern Med       Date:  2008-06-30       Impact factor: 25.391

Review 7.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.

Authors:  Molebogeng X Rangaka; Katalin A Wilkinson; Judith R Glynn; Daphne Ling; Dick Menzies; Judith Mwansa-Kambafwile; Katherine Fielding; Robert J Wilkinson; Madhukar Pai
Journal:  Lancet Infect Dis       Date:  2011-08-16       Impact factor: 25.071

8.  Serial testing with the interferon-γ release assay in Portuguese healthcare workers.

Authors:  José Torres Costa; Rui Silva; Raul Sá; Maria João Cardoso; Albert Nienhaus
Journal:  Int Arch Occup Environ Health       Date:  2010-08-19       Impact factor: 3.015
  8 in total
  12 in total

Review 1.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

2.  Pharmacist perceptions of the New Mexico pharmacist-performed tuberculosis testing program.

Authors:  Stefanie J Logothetis; Matthew E Borrego; Melissa H Roberts; Amy Bachyrycz; Graham S Timmins; Bernadette Jakeman
Journal:  J Am Pharm Assoc (2003)       Date:  2018-09-28

3.  Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.

Authors:  Dumitru Chesov; Christoph Lange; Franziska Daduna; Valeriu Crudu; Rosemarie Preyer; Martin Ernst; Barbara Kalsdorf
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

4.  Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.

Authors:  Nikoloz Chkhartishvili; Russell R Kempker; Natia Dvali; Lela Abashidze; Lali Sharavdze; Pati Gabunia; Henry M Blumberg; Carlos Del Rio; Tengiz Tsertsvadze
Journal:  BMC Infect Dis       Date:  2013-11-01       Impact factor: 3.090

5.  Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.

Authors:  Mary Ann De Groote; Michael Higgins; Thomas Hraha; Kirsten Wall; Michael L Wilson; David G Sterling; Nebojsa Janjic; Randall Reves; Urs A Ochsner; Robert Belknap
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

6.  Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.

Authors:  Zakeya A Bukhary; Soliman M Amer; Magdy M Emara; Mohammad E Abdalla; Sahar A Ali
Journal:  Ann Saudi Med       Date:  2018 Mar-Apr       Impact factor: 1.526

7.  The positive tuberculin test is not synonymous with latent tuberculosis.

Authors:  N Bocanegra-Román; A Verdeguer-Abad; J Osada
Journal:  Rev Esp Sanid Penit       Date:  2019

Review 8.  Heme Oxygenase-1 as a Pharmacological Target for Host-Directed Therapy to Limit Tuberculosis Associated Immunopathology.

Authors:  Krishna C Chinta; Hayden T Pacl; Anupam Agarwal; Adrie J C Steyn
Journal:  Antioxidants (Basel)       Date:  2021-01-26

9.  Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study.

Authors:  Sanghyuk S Shin; Manuel Gallardo; Remedios Lozada; Daniela Abramovitz; Jose Luis Burgos; Rafael Laniado-Laborin; Timothy C Rodwell; Thomas E Novotny; Steffanie A Strathdee; Richard S Garfein
Journal:  Pulm Med       Date:  2012-12-10

10.  Vitamin D status contributes to the antimicrobial activity of macrophages against Mycobacterium leprae.

Authors:  Elliot W Kim; Rosane M B Teles; Salem Haile; Philip T Liu; Robert L Modlin
Journal:  PLoS Negl Trop Dis       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.